Condition: Lung Adenocarcinoma · Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
This study aims to evaluate the non-inferiority in recurrence-free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma ≤ 2 cm with micropapillary and solid subtype negative by intraoperative frozen sections.
This description comes directly from the study's public registry record.
Hang Su · +86 13917810850 · dreamsuhang@163.com
Chang Chen, MD, PhD · +86 021-65115006 · chenthoracic@163.com
Always discuss trial participation with your own doctor first.
| Anhui Chest Hospital | Hefei, Anhui, China | Recruiting |
| The First Affiliated Hospital of University of Science and Technology of China | Hefei, Anhui, China | Recruiting |
| Nanyang Central Hospital | Nanyang, Henan, China | Recruiting |
| The Sixth People's Hospital of Nantong | Nantong, Jiangsu, China | Recruiting |
| Affiliated Hospital of Nantong University | Nantong, Jiangsu, China | Recruiting |
| Affiliated Hospital of Xuzhou Medical University | Xuzhou, Jiangsu, China | Recruiting |
| Yancheng First People's Hospital | Yancheng, Jiangsu, China | Recruiting |
| Shandong Public Health Clinical Center | Jinan, Shandong, China | Recruiting |
| Shanghai Pulmonary Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Huadong Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| Huzhou Central Hospital | Huzhou, Zhejiang, China | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04937283